On Tuesday, May 11, 2021, several changes will be made to the information displayed on the Mayo Clinic Laboratories online test catalog. These changes will improve accuracy and clarity of important information regarding test performanc
The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.
The pandemic has brought forth extraordinary challenges but also shined a light on the importance of laboratory professionals in health care.
Dr. Guenzel, a fellow in Laboratory Genetics and Genomics at Mayo Clinic, is the recipient of this award for his publication “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.”
Dr. Mills’ experience working with live cell bio-assays propelled him to centerstage in Mayo Clinic’s pursuit of a test to neutralize COVID-19 antibodies and aid in the development of therapies derived from COVID-19 patients' donated plasma.
On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
A case study published on Practice Greenhealth detailed how the change in freezers will reduce energy use by more than 60% and save more than $6 million over 10 years.
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
Dr. Binnicker's experience developing Mayo Clinic's first diagnostic COVID-19 test was recently featured in Mayo Clinic Alumni magazine.
Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
The assay is now recommended for diagnosing and monitoring patients with monoclonal protein disorders and exclusively available through Mayo Clinic Laboratories– Rochester.